Advanced Product Quality Planning (APQP Sample Clauses

Advanced Product Quality Planning (APQP. The Seller will provide an annual Quality & Reliability Assurance Plan (QP), which identifies how the Seller will achieve the Buyer’s quality goals for the products, services, and support provided by the Seller or Seller’s supply chain. The revised QP will be provided to the Buyer’s QA Representative whenever it is updated. The Buyer has the right to modify or offer recommendations to the goals, priorities, and activities in the QP to ensure that the QP is in full support of the Buyer’s business needs. Some of the areas that should be addressed in the QP are; · Annual quality objectives necessary for achievement of FPY rate · New product qualification requirements · Design tolerance evaluations to assure no mismatches in mating parts exist · Product quality requirement definitions, including cosmetic · Product quality requirements for production release · Production tool identification, tracking, and reporting requirements · Nonconforming product control and material purge requirements · Product inspection and test requirements, including burn-in time · Inspection and test sampling plans, IQC, in-process, final, OBA, and ORT · Product test matrix management and verification requirements · Quality Alert process definition, escalation, and closure criteria · Product change control verification and validation requirements · Customer complaint response, escalation, and closure requirements · Sub-supplier part qualification and production release requirements
Sample 1
AutoNDA by SimpleDocs
Advanced Product Quality Planning (APQP. When required by Buyer, the Supplier shall employ APQP in the development through launch of product(s) purchased by Buyer.
Sample 1
Advanced Product Quality Planning (APQP. 4.1 Supplier will manage the development phase of this program with the program team, technical support, production process, equipment, and personnel presented to Benteler during the technical review conducted prior to the award of the business. 4.2 Supplier will conduct a thorough feasibility assessment on each part prior to accepting the business award from Benteler and again prior to design release. Supplier will communicate any concerns relative to the program feasibility or success to Benteler in a timely manner. 4.3 Supplier will use suitable program management methods and tools to ensure a well managed development program and launch. 4.4 Supplier agrees to utilize the Benteler APQP Tool within the Newtron Web Portal to manage their development program. 4.4.1 Supplier understands that the questions asked within the Newtron APQP Tool define the expectations of Benteler relative to program development/APQP timing and content. 4.4.2 Supplier agrees to provide accurate and timely information based on the Benteler APQP Milestone Timing and provide updated timelines and an open issues list throughout the development program. 4.4.3 Supplier agrees to inform Benteler of any risks to the program timing or launch success in a timely and appropriate manner.
Sample 1
Advanced Product Quality Planning (APQP. ‌ The Supplier, who is going to supply to the Customer products for automotive or medical industry or, if it is so specified by the Customer, is obliged to follow the guidelines of the APQP process which are given in the APQP Manual issued by the Automotive Industry Action Group (AIAG, xxxxx://xxx.xxxx.xxx/). Goal of this approach is to plan and satisfy all agreed Customer's expectations for the contractual Product by using planned, controlled and standardized method of project management. Suppliers who do not supply products for automotive or medical programmes, are allowed to use simplified project management approach, managed over a project plan with defined key actions and milestones that are aligned with the Customer in the initial stage of the project. Goal of it shall be a timely submission of complete product qualification documentation (PPAP), which shall comply with the Customer's requirements (e.g.: Customer's PPAP requirements). When planning the APQP process, it is necessary to take into account the Customer's Product and APQP process management specific requirements (e.g.: use of Customer's APQP form). In the initial stage of the project (“kick-off”), the Supplier is obliged to make and submit to the Customer a project plan which will define key project steps, such as key milestones, key activities, target implementation dates and responsible persons for realisation of these activities. With Product dedicated project plan, the Supplier must ensure that project targets, such as quality requirements, Customer's specific requirements and timely realization of the project are met. • Evaluation of Customer's requirements. • Performance of Feasibility Study. • Defining process flow diagram. • Preparation of control plans (prototypes, pre-serial, serial). • Evaluation of D-FMEA products (if relevant). • Evaluation of P-FMEA process. • MSA. • SPC analyses. • Product test plan (functional and life tests). • Product measurements. • Specifying requirements towards Suppliers. • Evaluation and approval of the purchased products. • Defining packaging and transportation specification. • Evaluation of capacities (Run@Rate). • Making and submitting of the PPAP documents. • Planning of trial series till PPAP. Figure 1: APQP process
Sample 1
Advanced Product Quality Planning (APQP. Supplier will manage the development phase of this program with the program team, technical support, production process, equipment, and personnel presented to Benteler during the technical review conducted prior to the award of the business. Supplier will conduct a thorough feasibility assessment on each part prior to accepting the business award from Benteler and again prior to design release. Supplier will communicate any concerns relative to the program feasibility or success to Benteler in a timely manner. Supplier will use suitable program management methods and tools to ensure a well managed development program and launch. Supplier agrees to utilize the Benteler APQP Tool within the Newtron Web Portal to manage their development program. Supplier understands that the questions asked within the Newtron APQP Tool define the expectations of Benteler relative to program development/APQP timing and content. Supplier agrees to provide accurate and timely information based on the Benteler APQP Milestone Timing and provide updated timelines and an open issues list throughout the development program. Supplier agrees to inform Benteler of any risks to the program timing or launch success in a timely and appropriate manner. Supplier shall provide a pre-production parts plan subject to approval by Benteler’s Supplier Quality Engineer (“SQE”) which shall ensure, without limitation, each of the following: A pre-production warrant has been signed by the Benteler SQE for each Part Number prior to shipment of parts. Pre-production packaging has been discussed with and agreed to by the Benteler SQE. The Benteler LO_02 - Sample/Pre-production/Changed_Part Label is utilized for all pre-production parts shipped to Benteler facilities. The pre-production control plan (incoming goods through pack & delivery to Benteler) and gage methodology have been reviewed and approved by the Benteler SQE. Pre-production documentation relative to verification of dimensions, SC/CCs, material specification, and functional requirements have been discussed with and approved by the Benteler SQE. If required by Benteler’s customer, Supplier will submit their material data in IMDS and receive approval prior to the shipment of the pre-production parts. As part of the production process sign-off, Benteler reserves the right to carry out an extensive process acceptance run (Run @ Rate), on Supplier’s site under serial production conditions. Unless otherwise agreed to by the Benteler SQE, Supplier...
Sample 1
Advanced Product Quality Planning (APQP. Supplier and its sub-suppliers shall have a comprehensive APQP process in place in accordance to the latest AIAG and Continental’s requirements. Suppliers shall maintain APQP using the SupplyOn service “Project Management” for each component development project. Based on these requirements Continental has the opportunity to verify the APQP process at the Supplier as well as at the sub-supplier's premises together with its customer. The Supplier shall have a designated project engineer / manager for each component development project, who will be available upon request by Continental to be part of the overall project team.
Sample 1
Advanced Product Quality Planning (APQP. 5.1 APQP is a key element for new part introduction at the Buyer. 5.2 The Seller shall cooperate with Buyer upon request, to work on the System FMEA of the application. 5.3 The Buyer demands an APQP for all new Products’ requests. The APQP is confidential information and may be reviewed by Buyer on regular basis. 5.4 Requested APQP details have to be defined prior to sourcing with the Seller. The Parties shall consider the necessary qualification path respecting the application requirements. 5.5 Starting from the APQP phase, Seller shall develop and apply all tasks, tests, firewall and screening, in order to move towards 0 defect goal. 5.6 The Seller shall deliver the Products in suitable shipping packaging (and according to Buyer requirements, when specified), in order to prevent damages and quality impairments. 1 Form is the shape, size, dimension, mass, weight and other visual parameters which uniquely characterize an item. Fit is the ability of an item to physically interface or interconnect with or become an integral part of another item. Finally, Function is the action or actions that an item is designed to perform
Sample 1
AutoNDA by SimpleDocs

Related to Advanced Product Quality Planning (APQP

  • Product Quality Isoprene, (hereinafter referred to as “Product”) supplied and maintained on consignment at Belpre in accordance with Article 6, and will be in accordance with specifications set forth in Exhibit A. Seller will facsimile to the Buyer at time of shipment a Certificate of Analysis (COA). Seller will provide Buyer six (6) months advanced notification if there is a change in the manufacturing process that will affect the material specifications of Product provided to the Buyer. Product produced by the Seller in different plants is viewed as coming from different supply sources and requires separate qualifications. Product to be shipped for the Seller from third parties must be from a third party qualified by the Buyer based on Buyer’s criteria as specified in Exhibit B. Buyer will have the right to confirm each such shipment-conforms to the agreed specification; Seller must obtain approval prior to shipment any material that does not meet the Buyers specifications. If Seller deliveries Product failing to comply with the specifications set out in Exhibit A, Seller will reimburse Buyer for freight expenses associated with such shipment and be entitled at its option to i) require Seller to replace such defective Product at a price not to exceed the invoice value or ii) to reimburse the invoice value of the defective Product. If, Buyer has cause to complain that the quality of Product delivered to it pursuant to the Contract does not comply with the specification set out in Exhibit A, Buyer will give written notice specifying the nature of its complaint and the parties will promptly meet so as to resolve that complaint. In absence of any agreement to resolve the complaint the parties will appoint at their joint cost a mutually acceptable independent surveyor to examine whether the quality of Product as delivered complied with the specifications set forth in Exhibit A. In the absence of any written notice from Buyer to Seller within 30 days after delivery of the Product, the Product shall be deemed to have been delivered and accepted by Buyer in a satisfactory condition and in all respects in accordance with the specifications and Seller shall have no liability to Buyer with respect to that delivery.

  • Manufacturing Services Patheon will perform the Manufacturing Services for Products to be distributed and sold by Client in the Territory for the fees specified in Schedules B and C to the relevant Product Agreement. Schedule B to each Product Agreement sets forth a list of cost items that are included in the Price for Products; all cost items that are not included in this list are excluded from the Price and are subject to additional fees to be paid by Client. Patheon may amend the fees set out in Schedules B and C to a Product Agreement as set forth in Article 4. Patheon will perform the Manufacturing Services solely at the Manufacturing Site, unless otherwise agreed in writing by Client. If the parties agree that Patheon will supply, and Client will purchase, at least a specified minimum percentage of Client’s requirements for a Product under a Product Agreement (the “Required Percentage”), then the applicable Product Agreement will set forth the Required Percentage and the time period during which the obligation will apply (the “Required Period”). But this obligation (if any) will cease to apply to Client with respect to the Product if Patheon fails to remain in material compliance with its obligations under this Agreement or the applicable Product Agreement, or Patheon suspends performance under this Agreement or the applicable Product Agreement in connection with a Force Majeure Event or where Patheon is or will be prevented from supplying the Product as a result of the action of a Regulatory Authority. Subject to its obligation (if any) to purchase the Required Percentage of a Product during the Required Period, Client may, at any time, obtain Product from a third party or may, at any time, qualify a third party to perform Manufacturing Services for the Product. In performing the Manufacturing Services, Patheon and Client agree that:

  • Loss Leader; Recycled Products Contractor shall not sell or use any article or product as a “loss leader” as defined in Section 17030 of the Business and Professions Code. If Contractor will sell to the Judicial Council, or use in the performance of this Agreement, goods specified in PCC 12207 (for example, certain paper products, office supplies, mulch, glass products, lubricating oils, plastic products, paint, antifreeze, tires and tire-derived products, and metal products), then with respect to those goods: (i) Contractor shall use recycled products in the performance of this Agreement to the maximum extent doing so is economically feasible, and (ii) upon request, Contractor shall certify in writing under penalty of perjury, the minimum, if not exact, percentage of post consumer material as defined in the PCC 12200, in such goods regardless of whether the goods meet the requirements of PCC 12209.

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Product Recall (a) If a recall is required by applicable Law, or if Buyer or Supplier reasonably determines that a recall is advisable because the goods may create a potential safety hazard, are not in compliance with any applicable code, standard or legal requirement, or contain a defect or non-conformance with the requirements of this Order occurring or likely to occur in multiple goods, which such defects or non-conformances are substantially similar or have substantially similar causes or effects (collectively a “Serial Defect”), the parties shall promptly communicate such facts to each other. At Buyer’s request, Supplier shall promptly develop a corrective action plan satisfactory to Buyer, which shall include all actions required to recall and/or repair the goods and any actions required by applicable Law (“Corrective Action Plan”) for Buyer’s review and approval. At Buyer’s election, Xxxxx may develop the Corrective Action Plan. In no event shall Buyer and Supplier’s failure to agree on the Corrective Action Plan delay the timely notification of a potential safety hazard, non-compliance or Serial Defect to users of the goods, cause either party to be non-compliant with applicable Law or prevent Buyer from taking reasonable actions to prevent injury or damage to persons, equipment or other property. Supplier and Buyer shall cooperate with and assist each other in any corrective actions and/or filings, if applicable. (b) To the extent a recall is required by applicable Law, or due to a potential safety hazard, non-compliance or Serial Defect, which is caused by Supplier, Supplier shall indemnify and hold Buyer harmless from all reasonable costs and expenses incurred in connection with any recall, repair, replacement or refund program, including all costs related to: (i) investigating and/or inspecting the affected goods; (ii) notifying Buyer’s customers; (iii) repairing, or where repair of the goods is impracticable or impossible, repurchasing or replacing the recalled goods; (iv) packing and shipping the recalled goods; and (v) media notification. Each party shall consult the other before making any statements to the public or a governmental agency relating to such recall, potential safety hazard, non- compliance or Serial Defect, except where such consultation would prevent timely notification required by Law.

  • Commercialization Plan At such times as the JGC will deem appropriate, the JGC will direct the Parties to mutually prepare a Worldwide Commercialization Plan, and the JGC will review and approve such initial Worldwide Commercialization Plan. Thereafter, the JGC will have one or the other Party (or both) update the Worldwide Commercialization Plan each calendar year, and the JGC will review and approve any such update or any other amendment to the Worldwide Commercialization Plan. Notwithstanding anything in this CCPS Agreement to the contrary, the Parties acknowledge and agree that (i) Bluebird may decline to perform any Commercialization activity proposed to be conducted by Bluebird in the Worldwide Commercialization Plan (other than Manufacturing of Vectors and associated Payloads), and (ii) the Worldwide Commercialization Plan will not include, and Bluebird will have no obligation to perform, any such Commercialization activity that Bluebird has declined to perform, provided that once Bluebird has agreed to perform a Commercialization activity, it will be obligated to perform, and cannot decline to perform, such activity. In addition, either Party may request at any time that the JGC consider and approve other updates to the Worldwide Commercialization Plan. Further: (a) The JGC will set the required form and contents of the Worldwide Commercialization Plan. The Worldwide Commercialization Plan will reflect a singular marketing and sales approach worldwide, and will specify, among other things, the number of sales reps in the U.S. for each Party, allocation of regions in the U.S. for each Parties’ sales force, creation of marketing materials, planning for conferences, and other marketing activities. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. (b) Neither Party (itself or by or through any others, including any Affiliates or Sublicensees) will take any material action regarding the Commercialization of Licensed Product unless described in the Worldwide Commercialization Plan or approved by the JGC. (c) All Commercialization of Licensed Product for U.S. Administration will be conducted under the supervision of the JGC and as part of the U.S. Development & Commercialization Program. (d) Celgene will have final decision making authority for all Commercialization activities worldwide, including timing of launch and pricing and the Worldwide Development Plan.

  • Product Recalls (a) If either Party reasonably decides or is required by any government authority or court of competent jurisdiction, to initiate a product recall, withdrawal or field correction with respect to, or if there is any governmental seizure of, the Product, the Party initiating or required to initiate such action will notify the other Party promptly of the details regarding such action, including providing copies of all relevant documentation concerning such action. The Parties will assist each other in investigating any such situation and all regulatory contacts that are made and all activities concerning seizure, recall, withdrawal or field correction will be jointly coordinated by HSL and LMI. (b) If any such recall, withdrawal, field correction or seizure occurs due solely to (i) failure of any Product produced by HSL hereunder to conform to Specifications (including, without limitation, being adulterated or misbranded) or any warranty or other requirement set forth in this Agreement, (ii) the failure of HSL to comply in all material respects with any applicable law, rule, regulation, guideline, standard, court order or decree or (iii) the negligent or intentional wrongful act or omission of HSL in connection with the production of Product hereunder, then HSL shall bear the **** of any such seizure, recall, withdrawal or field correction and shall reimburse LMI for its ****, including any purchase price payments made to HSL and related taxes to the extent related to such recalled Product. To the extent any such recall, withdrawal, field correction or seizure occurs for any reason other than that set forth in the immediately preceding sentence, then LMI shall bear the **** of any such seizure, recall, withdrawal or field correction. If both HSL and LMI contribute to the cause of a seizure, recall, withdrawal or field correction, the cost and expense thereof will be shared in proportion to each Party’s contribution to the problem. For the purposes of this Agreement, the expenses of any recall, withdrawal, field correction or seizure shall include, without limitation, the out-of-pocket expenses of notification and destruction or return of the recalled Product and all other out-of-pocket costs incurred in connection with such recall but shall not include a Party’s lost profits. HSL’s reimbursement for the costs of LMI Materials related to such recall, withdrawal or field correction is limited by Section 5.6(c).

  • Additional Products Upon satisfying the minimum order requirements above, Enrolled Affiliate may order Additional Products.

  • Product Sales Subject to Sections 10.3(c) and 10.3(d), Licensee agrees that it will not sell, offer for sale, or assist third parties (including Affiliates) in selling Product except for the sale and offer for sale of (A) TAF Product, TAF Combination Product, TDF Product and TDF Combination Product for use in the Field and in the countries of the TDF-TAF Territory, (B) COBI Product and COBI Combination Product for use in the Field and in the countries of the COBI Territory, and (C) EVG Product, EVG Combination Product and Quad Product for use in the Field and in the countries of the EVG-Quad Territory.‌ (i) Licensee agrees that during the period in which the Patents are valid and enforceable (on a Product-by-Product basis) it will prohibit its Distributors from selling Product (A) to any other wholesaler or distributor, (B) outside the Territory for which Licensee is licensed for sale of such Product pursuant to Section 2.2, or (C) for any purpose outside the Field. (ii) Licensee agrees that it will not administer the TAF Quad to humans, or sell the TAF Quad until Gilead has obtained marketing approval for the TAF Quad from the FDA. Licensee agrees that it will not administer EVG to humans, or sell Products containing EVG until Gilead has obtained marketing approval for an EVG Product from the FDA. Licensee agrees that it will not administer COBI to humans, or sell Products containing COBI until Gilead has obtained marketing approval for a COBI Product from the FDA. Licensee agrees that it will not administer TAF to humans, or sell Products containing TAF until Gilead has obtained marketing approval for a TAF Product from the FDA. If Gilead obtains marketing approval from the FDA for any Quad Product or a Combination Product containing TAF, COBI or EVG (“Approved Combination Product”) prior to obtaining marketing approval for a TAF Product, EVG Product or COBI Product from the FDA, then Licensee will be allowed to administer such Quad Product or such Approved Combination Product to humans, and sell such Quad Product or such Approved Combination Product from and after the date of such marketing approval from the FDA, but will not (A) administer to humans or sell Combination Products containing EVG other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for an EVG Product, or (B) administer to humans or sell Combination Products containing COBI other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a COBI Product or (C) administer to humans or sell Combination Products containing TAF other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a TAF Product.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!